Mar 16, 2025 · Evolocumab (brand name Repatha) is a PCSK9 inhibitor used for hypercholesterolemia (high cholesterol) and cardiovascular risk reduction. It is given by …

Evolocumab, [6] sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab is a fully human …

Mar 12, 2025 · Repatha (evolocumab) is an injectable prescription medicine approved: to reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular …

It is also used to reduce the risk of death, heart attack, stroke, unstable angina (chest pain) requiring hospitalization, or certain types of heart surgery in patients with existing heart or …

Mar 17, 2017 · Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by …

May 21, 2024 · Find patient medical information for Repatha (evolocumab) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

What is Repatha® (evolocumab)? To reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest …

Jan 6, 2025 · Learn about the side effects of evolocumab, from common to rare, for consumers and healthcare professionals.

Adjunct to diet, alone or in combination with other lipid-lowering therapies (eg, statins), for treatment of primary hyperlipidemia, including heterozygous familial hyperlipidemia (HeFH), to …

View evolocumab information, including dose, uses, side-effects, pregnancy, breast feeding and drug action.